oxazoles has been researched along with Complications of Diabetes Mellitus in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Adeghate, E; Csekő, K; Dányádi, B; Deres, L; Ferdinandy, P; Gábriel, R; Halmosi, R; Helyes, Z; Horváth, ÁI; Kőszegi, T; Kovács-Valasek, A; Mátyus, P; Pintér, E; Sághy, É; Szabadfi, K; Tékus, V; Varga, ZV | 1 |
| Cosentino, F; Grobbee, DE; Lincoff, AM; Mellbin, L; Morici, N; Nozza, A; Perrone Filardi, P; Ponticelli, C; Savonitto, S; Schrieks, IC; Schwartz, GG; Stähli, BE; Tardif, JC | 1 |
| Okamoto, T; Park, CH; Toriizuka, K; Yamabe, N; Yokozawa, T | 1 |
| Kourilsky, O; Meurin, P | 1 |
| Cao, YL; Li, S; Liu, HY; Ruan, CM; Wang, LL; Xu, C; Zhou, XB | 1 |
| Robles, NR | 1 |
| Schachter, M | 1 |
| Ketelslegers, JM; Lambert, AE; Mpoy, M; Vandeleene, B | 1 |
1 review(s) available for oxazoles and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Metabolic effects of moxonidine and other centrally acting antihypertensives.
Topics: Animals; Antihypertensive Agents; Diabetes Complications; Humans; Hypertension; Imidazoles; Insulin Resistance; Metabolism; Oxazoles; Rilmenidine; Sympathetic Nervous System; Sympatholytics; Syndrome | 1999 |
2 trial(s) available for oxazoles and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Albuminuria; Analysis of Variance; Biomarkers; Cause of Death; Comorbidity; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Male; Oxazoles; Patient Discharge; Percutaneous Coronary Intervention; Peroxisome Proliferator-Activated Receptors; Predictive Value of Tests; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Thiophenes | 2017 |
[Efficacy and acceptability of rilmenidine in a population of 2 738 hypertensive diabetic patients].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Mass Index; Diabetes Complications; Diastole; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Oxazoles; Rilmenidine; Risk Factors; Time Factors | 2002 |
5 other study(ies) available for oxazoles and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats.
Topics: Amine Oxidase (Copper-Containing); Analgesics; Animals; Cell Adhesion Molecules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Hydrazines; Insulin; Insulin-Secreting Cells; Male; Monoamine Oxidase Inhibitors; Oxazoles; Oximes; Rats; Rats, Sprague-Dawley; Streptozocin | 2021 |
Chinese prescription kangen-karyu ameliorates the development of diabetic hepatic damages via regulating oxidative stress and inflammation in the liver of db/db mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cyclooxygenase Inhibitors; Diabetes Complications; Drugs, Chinese Herbal; Glucose; Hyperglycemia; Inflammation; Inflammation Mediators; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type II; Oxazoles; Oxidative Stress; Phytotherapy | 2011 |
A novel dual peroxisome proliferator-activated receptors alpha and gamma agonist with beneficial effects on insulin resistance and lipid metabolism.
Topics: Adipocytes; Adipogenesis; Animals; Cell Differentiation; Diabetes Complications; Humans; Insulin Resistance; Lipid Metabolism; Male; Mice; Models, Animal; Oxazoles; PPAR alpha; PPAR gamma; Tyrosine; Up-Regulation | 2006 |
[New central agents in the treatment of arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Clonidine; Diabetes Complications; Humans; Hypertension; Imidazoles; Nifedipine; Oxazoles; Renin-Angiotensin System; Reserpine; Rilmenidine; Risk Factors; Sympathetic Nervous System; Vasodilator Agents | 1999 |
Treatment of hypertension in diabetic patients.
Topics: Antihypertensive Agents; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Oxazoles; Rilmenidine | 1989 |